Literature DB >> 11927752

The prevalence of distress in persons with human immunodeficiency virus infection.

MaryAnn Cohen1, Rosalind G Hoffman, Caroline Cromwell, James Schmeidler, Fahmy Ebrahim, Gloria Carrera, Fred Endorf, Cesar A Alfonso, Jeffrey M Jacobson.   

Abstract

The purpose of this study was to assess the prevalence of distress, anxiety, and depression in persons with human immunodeficiency virus (HIV) infection and determine the feasibility of screening in an urban HIV primary care setting. A convenience sample of 101 patients in the waiting room of an acquired immunodeficiency syndrome clinic completed two questionnaires, the Hospital Anxiety and Depression Scale (HADS) and the Distress Thermometer. The patient's demographic, medical, and psychiatric histories were obtained through chart review. The results of the Distress Thermometer revealed that 72.3% had a score of 5 or greater, demonstrating high distress. The results of the HADS revealed that 70.3% had high anxiety, with a score of 7 or greater. On the HADS depression questions, 45.5% had a score of 7 or greater, indicating depression. Analysis of the total HADS scores, including anxiety and depression, revealed that 53.5% had a score of greater than 15 and were experiencing significant distress. Patients with high viral loads were more likely to be distressed (P < 0.0005). Patients with high viral loads were also more likely to have higher anxiety or depression scores on the HADS. Patients who had CD4 counts higher than 500/mm(3) were less likely to be depressed. This study demonstrates a high prevalence of distress, anxiety, and depression among persons with HIV. The HADS and the Distress Thermometer showed a good correlation with each other (P < 0.0005), and these questionnaires can provide a simple and efficient method for rapid screening in an HIV clinic setting.

Entities:  

Mesh:

Year:  2002        PMID: 11927752     DOI: 10.1176/appi.psy.43.1.10

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  12 in total

1.  A Social Problem-Solving Model of Adherence to HIV Medications.

Authors:  Mallory O Johnson; Timothy R Elliott; Torsten B Neilands; Stephen F Morin; Margaret A Chesney
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

2.  Silent endurance and profound loneliness: socioemotional suffering in African Americans living with HIV in the rural south.

Authors:  Margaret Shandor Miles; Malika Roman Isler; Bahby B Banks; Sohini Sengupta; Giselle Corbie-Smith
Journal:  Qual Health Res       Date:  2010-11-01

3.  Psychosocial factors as predictors of HIV/AIDS risky behaviors among people living with HIV/AIDS.

Authors:  Gemechu B Gerbi; Tsegaye Habtemariam; Vinaida Robnett; David Nganwa; Berhanu Tameru
Journal:  J AIDS HIV Res       Date:  2012-01-01

4.  Use of the Distress Thermometer to discern clinically relevant quality of life differences in women with breast cancer.

Authors:  Barbara Anderson Head; Tara J Schapmire; Cynthia Ellis Keeney; Stacy M Deck; Jamie L Studts; Carla P Hermann; Jennifer A Scharfenberger; Mark Paul Pfeifer
Journal:  Qual Life Res       Date:  2011-05-29       Impact factor: 4.147

5.  Self-efficacy and distress in women with AIDS: the SMART/EST women's project.

Authors:  Deborah L Jones; Mary Ishii Owens; David Lydston; Jonathan N Tobin; Elizabeth Brondolo; Stephen M Weiss
Journal:  AIDS Care       Date:  2010-12

Review 6.  Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.

Authors:  Geetanjali Chander; Seth Himelhoch; Richard D Moore
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  A quantitative risk assessment of multiple factors influencing HIV/AIDS transmission through unprotected sex among HIV-seropositive men.

Authors:  Gemechu B Gerbi; Tsegaye Habtemariam; Berhanu Tameru; David Nganwa; Vinaida Robnett
Journal:  AIDS Care       Date:  2011-09-07

8.  Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals.

Authors:  Monique M R de Maat; Alwin D R Huitema; Jan W Mulder; Pieter L Meenhorst; Eric C M van Gorp; Albert T A Mairuhu; Jos H Beijnen
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

9.  Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil.

Authors:  Lorenza Nogueira Campos; Mark Drew Crosland Guimarães; Robert H Remien
Journal:  AIDS Behav       Date:  2008-07-22

10.  Disclosure and Experienced Social Support are not Related to Anxiety or Depression in a German HIV Patient Cohort.

Authors:  Jens M Kittner; Felix Brokamp; Thomas Thomaidis; Reinhold E Schmidt; Jörg Wiltink; Peter R Galle; Burkard Jäger
Journal:  Infect Chemother       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.